India's drug regulator has issued a new directive for pharmaceutical companies. Periodic Safety Update Reports for new drugs must now be su...

India's drug regulator CDSCO has issued new rules for drug safety reporting. Companies must now submit safety reports from the actual launc...

Weight-loss drugs are being sold without prescriptions in India. This is causing alarm among doctors and authorities. People are buying the...

Despite ongoing debate, medications such as Ozempic continue to rank among the most commonly prescribed treatments for weight management an...

India's drug regulator has issued new safety warnings for common medicines. Doxycycline, an antibiotic, will now list side effects like anx...

The CDSCO has mandated that all retail and wholesale pharmacies across India must prominently display a QR code and a toll-free number. Thi...

Beta-blockers, used for irregular heartbeat and hypertension, can cause dangerously low potassium levels, known as hypokalaemia, according ...

The Indian Pharmacopoeia Commission has issued a drug safety alert regarding amlodipine and acetazolamide, highlighting potential adverse r...

Blue Cross Laboratories, the owner of the Meftal painkiller brand, has clarified that the adverse reaction the Indian Pharmacopoeia Commiss...

The commission, in its alert, stated that a preliminary analysis of adverse drug reactions from the Pharmacovigilance Programme of India (P...

The drug regulatory body also advised doctors and healthcare professionals to carefully prescribe and educate their patients to discontinue...

According to PvPI, there have been over 100 reported instances of adverse drug reactions associated with prophylactic use of HCQ, some bein...

The aim is to make the patients and doctors aware of the new adverse reactions of certain drugs which are prescribed frequently for certain...

Health Secretary BP Sharma said the importance of Pharmacovigilance has increased as there have been changes in the ways people take medici...

Health Minister JP Nadda today underlined the importance of pharmacovigilance, the monitoring of adverse effects of drugs in the country.

India plans to suspend sale of medicines that are banned in one of the six major global drug markets for harmful side-effects.

The government may make it compulsory for all hospitals and medical institutions to report adverse drug reactions, a move, which could enab...